BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan JX, Niu MT, Qin YT, Sun YX, Zhang XZ. Progress of engineered bacteria for tumor therapy. Adv Drug Deliv Rev 2022;185:114296. [PMID: 35439571 DOI: 10.1016/j.addr.2022.114296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Li Z, Mo F, Chen-Mayfield TJ, Saini A, LaMere AM, Hu Q. Chemically engineering cells for precision medicine. Chem Soc Rev 2023;52:1068-102. [PMID: 36633324 DOI: 10.1039/d2cs00142j] [Reference Citation Analysis]
2 Zheng Y, Wei Z, Wang T. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Front Endocrinol 2023;14. [DOI: 10.3389/fendo.2023.1120533] [Reference Citation Analysis]
3 He H, Zhu D, Ma A, Ren J, Chen Z, Ran H, Li Z, Qin R, Liang R, Liu L, Cai L. Reconstructing Tumor Microenvironment Using Photoresponsive Cyanobacteria to Reversal Chemoresistance for Robust Chemotherapy. Small Structures 2023. [DOI: 10.1002/sstr.202200325] [Reference Citation Analysis]
4 Chen Y, Li ZH, Zeng X, Zhang XZ. Bacteria-based bioactive materials for cancer imaging and therapy. Adv Drug Deliv Rev 2023;193:114696. [PMID: 36632868 DOI: 10.1016/j.addr.2023.114696] [Reference Citation Analysis]
5 Zeng S, Zheng D, Li R, Zhuang Z, Zhang Y, Sun Y, Zhang X. Functional Modification of Bacteria during Plasmolysis and Deplasmolysis for Tumor Diagnosis and Treatment. ACS Materials Lett 2022. [DOI: 10.1021/acsmaterialslett.2c00716] [Reference Citation Analysis]
6 Han D, Zhang X, Ma Y, Yang X, Li Z. The development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy. Mater Today Bio 2023;18:100517. [PMID: 36578285 DOI: 10.1016/j.mtbio.2022.100517] [Reference Citation Analysis]
7 Liu J, Sun X. Advances in bacteria-based therapy for drug delivery. Adv Drug Deliv Rev 2022;190:114565. [PMID: 36174790 DOI: 10.1016/j.addr.2022.114565] [Reference Citation Analysis]
8 Zhu X, Chen S, Hu X, Zhao L, Wang Y, Huang J, Chen J, Qiu Y, Zhang X, Wang M, Yang X, Zhang Y, Zhu Y. Near-Infrared Nano-Optogenetic Activation of Cancer Immunotherapy via Engineered Bacteria. Adv Mater 2022;:e2207198. [PMID: 36314411 DOI: 10.1002/adma.202207198] [Reference Citation Analysis]